Target network analysis of adiponectin, a multifaceted adipokine

Journal of Cellular Biochemistry

Volumn 114, Issue 5, 2013, Pages 1145-1152

  Chen, Xiuping ^a,b  

^a University of Macau   (Macao)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

adiponectin; clinical tried drug target; network analysis; research drug target; successful drug target

Indexed keywords

ADIPONECTIN; ANTISENSE OLIGONUCLEOTIDE;

ADIPOSE TISSUE; ARTICLE; CLINICAL TRIAL TARGETS NETWORK; CYTOKINE RELEASE; DATA BASE; DRUG SCREENING; DRUG TARGETING; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HUMAN; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RESEARCH TARGETS NETWORK; SIGNAL TRANSDUCTION; SUCCESSFUL TARGETS NETWORK; TOTAL TARGETS NETWORK;

EID: 84875178322     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24457     Document Type: Article

References (57)

1. Albert R,. 2005. Scale-free networks in cell biology. J Cell Sci 118: 4947-4957.
2. Assenov Y, Ramirez F, Schelhorn SE, Lengauer T, Albrecht M,. 2008. Computing topological parameters of biological networks. Bioinformatics 24: 282-284.
3. Behre CJ,. 2007. Adiponectin, obesity and atherosclerosis. Scand J Clin Lab Invest 67: 449-458.
4. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF,. 2010. Adiponectin action from head to toe. Endocrine 37: 11-32.
5. Buechler C, Wanninger J, Neumeier M,. 2010. Adiponectin receptor binding proteins-Recent advances in elucidating adiponectin signalling pathways. FEBS Lett 584: 4280-4286.
6. Chen X, Wang Y,. 2011. Adiponectin and breast cancer. Med Oncol 28: 1288-1295.
7. Chen X, Ji ZL, Chen YZ,. 2002. TTD: Therapeutic target database. Nucleic Acids Res 30: 412-415.
8. Chen X, Fang Y, Yao L, Chen Y, Xu H,. 2007a. Does drug-target have a likeness? Methods Inf Med 46: 360-366.
9. Chen X, Zheng CJ, Han LY, Xie B, Chen YZ,. 2007b. Trends in the exploration of therapeutic targets for the treatment of endocrine, metabolic and immune disorders. Endocr Metab Immune Disord Drug Targets 7: 225-231.
10. Chou KC, Cai YD,. 2006. Predicting protein-protein interactions from sequences in a hybridization space. J Proteome Res 5: 316-322.
11. Chou KC, Shen HB,. 2009. Recent advances in developing web-servers for predicting protein attributes. Nat Sci 1: 63-92.
12. Chou KC, Wu ZC, Xiao X,. 2012. iLoc-Hum: Using the accumulation-label scale to predict subcellular locations of human proteins with both single and multiple sites. Mol Biosyst 8: 629-641.
13. Doncheva NT, Assenov Y, Domingues FS, Albrecht M,. 2012. Topological analysis and interactive visualization of biological networks and protein structures. Nat Protoc 7: 670-685.
14. Gao P, Wang QP, Chen L, Huang T,. 2012. Prediction of human genes' regulatory functions based on protein-protein interaction network. Protein Pept Lett 19: 910-916.
15. Guebre-Egziabher F, Drai J, Fouque D,. 2007. Adiponectin and chronic kidney disease. J Ren Nutr 17: 9-12.
16. Han SH, Sakuma I, Shin EK, Koh KK,. 2009. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: Basic and clinical studies. Prog Cardiovasc Dis 52: 126-140.
17. Hase T, Tanaka H, Suzuki Y, Nakagawa S, Kitano H,. 2009. Structure of protein interaction networks and their implications on drug design. PLoS Comput Biol 5: e1000550.
18. Heiker JT, Kosel D, Beck-Sickinger AG,. 2010. Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors. Biol Chem 391: 1005-1018.
19. Hu L, Huang T, Shi X, Lu WC, Cai YD, Chou KC,. 2011a. Predicting functions of proteins in mouse based on weighted protein-protein interaction network and protein hybrid properties. PLoS ONE 6: e14556.
20. Hu LL, Huang T, Cai YD, Chou KC,. 2011b. Prediction of body fluids where proteins are secreted into based on protein interaction network. PLoS ONE 6: e22989.
21. Hu LL, Feng KY, Cai YD, Chou KC,. 2012. Using protein-protein interaction network information to predict the subcellular locations of proteins in budding yeast. Protein Pept Lett 19: 644-64451.
22. Huang T, Chen L, Cai YD, Chou KC,. 2011a. Classification and analysis of regulatory pathways using graph property, biochemical and physicochemical property, and functional property. PLoS ONE 6: e25297.
23. Huang T, Niu S, Xu Z, Huang Y, Kong X, Cai YD, Chou KC,. 2011b. Predicting transcriptional activity of multiple site p53 mutants based on hybrid properties. PLoS ONE 6: e22940.
24. Hui X, Lam KS, Vanhoutte PM, Xu A,. 2012. Adiponectin and cardiovascular health: An update. Br J Pharmacol 165: 574-590.
25. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T,. 2010. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464: 1313-1319.
26. Jasmine F, Rahaman R, Dodsworth C, Roy S, Paul R, Raza M, Paul-Brutus R, Kamal M, Ahsan H, Kibriya MG,. 2012. A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: Opportunities for future personalized treatment. PLoS ONE 7: e31968.
27. Kadowaki T, Yamauchi T,. 2005. Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451.
28. Kar G, Gursoy A, Keskin O,. 2009. Human cancer protein-protein interaction network: A structural perspective. PLoS Comput Biol 5: e1000601.
29. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, Kim SE, Lee GY, Lee JW, Jung SA, Chung HY, Jeong S, Kim JB,. 2010. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 24: 1441-1452.
30. Klipp E, Wade RC, Kummer U,. 2010. Biochemical network-based drug-target prediction. Curr Opin Biotechnol 21: 511-516.
31. Kusunoki N, Kitahara K, Kojima F, Tanaka N, Kaneko K, Endo H, Suguro T, Kawai S,. 2010. Adiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 62: 1641-1649.
32. Lee SW, Kim JH, Park MC, Park YB, Lee SK,. 2008. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol 37: 260-268.
33. Levy ED, Landry CR, Michnick SW,. 2009. How perfect can protein interactomes be? Sci Signal 2: pe11.
34. Li S, Shin HJ, Ding EL, van Dam RM,. 2009. Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 302: 179-188.
35. Li BQ, Huang T, Liu L, Cai YD, Chou KC,. 2012. Identification of colorectal cancer related genes with mRMR and shortest path in protein-protein interaction network. PLoS ONE 7: e33393.
36. Liao W, Yu C, Wen J, Jia W, Li G, Ke Y, Zhao S, Campell W,. 2009. Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biol Cell 101: 263-272.
37. Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, Accili D,. 2007. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 56: 1969-1976.
38. Lin CY, Chin CH, Wu HH, Chen SH, Ho CW, Ko MT,. 2008. Hubba: Hub objects analyzer-A framework of interactome hubs identification for network biology. Nucleic Acids Res 36: W438-W443.
39. Lin WZ, Fang JA, Xiao X, Chou KC,. 2011. iDNA-Prot: Identification of DNA binding proteins using random forest with grey model. PLoS ONE 6: e24756.
40. Liu ZP, Wang Y, Zhang XS, Chen L,. 2012. Network-based analysis of complex diseases. IET Syst Biol 6: 22-33.
41. Miyazaki T, Bub JD, Uzuki M, Iwamoto Y,. 2005. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun 333: 79-87.
42. Neumeier M, Bauer S, Bruhl H, Eisinger K, Kopp A, Abke S, Walter R, Schaffler A, Buechler C,. 2011. Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes. Cytokine 56: 573-580.
43. Robinson K, Prins J, Venkatesh B,. 2011. Clinical review: Adiponectin biology and its role in inflammation and critical illness. Crit Care 15: 221.
44. Ruffner H, Bauer A, Bouwmeester T,. 2007. Human protein-protein interaction networks and the value for drug discovery. Drug Discov Today 12: 709-716.
45. Semple RK, Cochran EK, Soos MA, Burling KA, Savage DB, Gorden P, O'Rahilly S,. 2008. Plasma adiponectin as a marker of insulin receptor dysfunction: Clinical utility in severe insulin resistance. Diabetes Care 31: 977-979.
46. Sharan R, Ideker T,. 2006. Modeling cellular machinery through biological network comparison. Nat Biotechnol 24: 427-433.
47. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K,. 2005. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103.
48. Sun H, Zhang Y, Gao P, Li Q, Sun Y, Zhang J, Xu C,. 2011. Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells. Mol Cell Biochem 347: 183-189.
49. Wang J, Huo K, Ma L, Tang L, Li D, Huang X, Yuan Y, Li C, Wang W, Guan W, Chen H, Jin C, Wei J, Zhang W, Yang Y, Liu Q, Zhou Y, Zhang C, Wu Z, Xu W, Zhang Y, Liu T, Yu D, Chen L, Zhu D, Zhong X, Kang L, Gan X, Yu X, Ma Q, Yan J, Zhou L, Liu Z, Zhu Y, Zhou T, He F, Yang X,. 2011a. Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol 7: 536.
50. Wang P, Xiao X, Chou KC,. 2011b. NR-2L: A two-level predictor for identifying nuclear receptor subfamilies based on sequence-derived features. PLoS ONE 6: e23505.
51. Wanninger J, Neumeier M, Weigert J, Bauer S, Weiss TS, Schaffler A, Krempl C, Bleyl C, Aslanidis C, Scholmerich J, Buechler C,. 2009. Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 297: G611-G618.
52. Wiles AM, Doderer M, Ruan J, Gu TT, Ravi D, Blackman B, Bishop AJ,. 2010. Building and analyzing protein interactome networks by cross-species comparisons. BMC Syst Biol 4: 36.
53. Wu ZC, Xiao X, Chou KC,. 2011. iLoc-Plant: A multi-label classifier for predicting the subcellular localization of plant proteins with both single and multiple sites. Mol Biosyst 7: 3287-3297.
54. Zhang X, Zhang R, Jiang Y, Sun P, Tang G, Wang X, Lv H, Li X,. 2011. The expanded human disease network combining protein-protein interaction information. Eur J Hum Genet 19: 783-788.
55. Zhu M, Gao L, Li X, Liu Z, Xu C, Yan Y, Walker E, Jiang W, Su B, Chen X, Lin H,. 2009. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target 17: 524-532.
56. Zhu F, Han B, Kumar P, Liu X, Ma X, Wei X, Huang L, Guo Y, Han L, Zheng C, Chen Y,. 2010. Update of TTD: Therapeutic target database. Nucleic Acids Res 38: D787-D791.
57. Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, Zhang L, Song Y, Zhang J, Han B, Zhang P, Chen Y,. 2012. Therapeutic target database update 2012: A resource for facilitating target-oriented drug discovery. Nucleic Acids Res 40: D1128-D1136.